DreamTel; diabetes risk evaluation and management tele-monitoring study protocol
Open accessAbstract
BACKGROUND: The rising prevalence of type 2 diabetes underlines the importance of secondary strategies for the prevention of target organ damage. While access to diabetes education centers and diabetes intensification management has been shown to improve blood glucose control, these services are not available to all that require them, particularly in rural and northern areas. The provision of these services through the Home Care team is an advance that can overcome these barriers. Transfer of blood glucose data electronically from the home to the health care provider may improve diabetes management. METHODS AND DESIGN: The study population will consist of patients with type 2 diabetes with uncontrolled A1c levels living on reserve in the Battlefords region of Saskatchewan, Canada. This pilot study will take place over three phases. In the first phase over three months the impact of the introduction of the Bluetooth enabled glucose monitor will be assessed. In the second phase over three months, the development of guidelines based treatment algorithms for diabetes intensification will be completed. In the third phase lasting 18 months, study subjects will have diabetes intensification according to the algorithms developed. DISCUSSION: The first phase will determine if the use of the Bluetooth enabled blood glucose devices which can transmit results electronically will lead to changes in A1c levels. It will also determine the feasibility of recruiting subjects to use this technology. The rest of the Diabetes Risk Evaluation and Management Tele-monitoring (DreamTel) study will determine if the delivery of a diabetes intensification management program by the Home Care team supported by the Bluetooth enabled glucose meters leads to improvements in diabetes management. TRIAL REGISTRATION: Protocol NCT00325624.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Providers default to therapeutic inertia, failing to titrate medications despite receiving actionable physiological data.
“Consequently, providers default to therapeutic inertia, failing to titrate medications despite receiving actionable physiological data [7,8].”
From Clinical Efficacy and Patient Adherence Hurdles of Remote Patient Monitoring (RPM) Frameworks in Managing Hypertension and Type 2 Diabetes: A Scoping Review (2026) · cites this paper as [7]
The Discussion (page unavailable) describes clinical inertia in poorly controlled diabetes and reports that more than 50% of patients referred to specialists had no treatment intensification within four months of a high-A1c lab report. The Methods and design section defines intensification to include increasing a medication dose. This supports failure to adjust treatment despite an actionable result, but not the broader claim that providers generally default to inertia despite receiving physiological data. (LLM, conf=0.83)
Experimental — accuracy not yet measuredClinical teams routinely experience alert fatigue, increased administrative workloads, and persistent therapeutic inertia when attempting to titrate medications based on remotely transmitted data.
“clinical teams routinely experience alert fatigue, increased administrative workloads, and persistent therapeutic inertia (delays in escalating treatment despite recorded clinical need) when attempting to titrate medications based on remotely transmitted data [7,8].”
From Clinical Efficacy and Patient Adherence Hurdles of Remote Patient Monitoring (RPM) Frameworks in Managing Hypertension and Type 2 Diabetes: A Scoping Review (2026) · cites this paper as [7]
The Discussion describes clinical inertia as a failure to intensify diabetes treatment despite evidence of poor control, and the Methods and design section describes adjusting medication using remotely available glucose readings. But the paper does not say that teams routinely experience alert fatigue or increased administrative workloads, or that remote-data titration itself causes persistent inertia. (LLM, conf=0.86)
Experimental — accuracy not yet measuredWhen an RPM platform shifts administrative or technical burdens onto clinical teams without automated triaging, it triggers alert fatigue.
“when an RPM platform shifts administrative or technical burdens onto clinical teams without automated triaging, it triggers alert fatigue [7].”
From Clinical Efficacy and Patient Adherence Hurdles of Remote Patient Monitoring (RPM) Frameworks in Managing Hypertension and Type 2 Diabetes: A Scoping Review (2026) · cites this paper as [7]
The Methods and design section describes a planned system of graded alerts, and the Discussion describes remote monitoring. Neither addresses whether shifting administrative or technical work to clinical teams without automated triaging causes alert fatigue. Searches for alert fatigue, triaging, and staff workload found no passage making that connection. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803 · see citing works
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · see citing works
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · see citing works
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,019 · see citing works
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447 · see citing works
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · see citing works
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515 · see citing works
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372 · see citing works
Booth, G. L., & CHENG, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.010 · Cited by 1,220 · see citing works
The Canadian Journal of Public Health in 2010
Paradis, G. (2010) · Canadian Journal of Public Health · doi:10.1007/bf03405549 · Cited by 781 · see citing works
Weingarten, S. R. (2002) · BMJ · doi:10.1136/bmj.325.7370.925 · Cited by 735 · see citing works
CHENG, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.009 · Cited by 728 · see citing works
The Diabetes Control and Complications (DCCT) Research Group (1995) · Kidney International · doi:10.1038/ki.1995.236 · Cited by 694 · see citing works
Lipscombe, L. L., & Hux, J. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60361-4 · Cited by 628 · see citing works
Paget's Disease of the Mandible
Patel, M., & Bhalla, A. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmicm066227 · Cited by 610 · see citing works
Aubert, R. E., Herman, W. H., Waters, J., Moore, W., SUTTON, D. R., Peterson, B. L., Bailey, C. M., & Koplan, J. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00004 · Cited by 561 · see citing works
Ruilope, L. M., Salvetti, A., Jamerson, K., Hansson, L., Warnold, I., Wedel, H., & Zanchetti, A. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122218 · Cited by 503 · see citing works
Rising Tide of Cardiovascular Disease in American Indians
Howard, B. V., Lee, E. T., Cowan, L. D., Devereux, R. B., Galloway, J. M., Go, O. T., Howard, W. J., Rhoades, E. R., Robbins, D. C., Sievers, M. L., et al. (1999) · Circulation · doi:10.1161/01.cir.99.18.2389 · Cited by 461 · see citing works
Clinical Inertia in Response to Inadequate Glycemic Control
Shah, B. R., Hux, J. E., Laupacis, A., Zinman, B., & van Walraven, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.600 · Cited by 387 · see citing works
International Journal of Circumpolar Health
Olli, T. K., Tuili, S., & Keistinen, T. T. (2011) · International Journal of Circumpolar Health · doi:10.3402/ijch.v70i3.17826 · Cited by 356 · see citing works
Cardiovascular Disease Risk Factors among American Indians
Welty, T. K., Lee, E. T., Yeh, J. L., Cowan, L. D., Go, O. T., Fabsitz, R. R., Le, N., Oopik, A. J., Robbins, D. C., & Howard, B. V. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117633 · Cited by 300 · see citing works
Anand, S. S., Yusuf, S., Jacobs, R., Davis, A. D., Yi, Q., Gerstein, H. C., Montague, P. A., & Lonn, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06255-9 · Cited by 298 · see citing works
Howard, B. V., Cowan, L. D., Go, O. T., Welty, T. K., Robbins, D. C., Lee, E. T., & Strong Heart Study Investigators (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1258 · Cited by 275 · see citing works
Coronary Heart Disease Prevalence and Its Relation to Risk Factors in American Indians
Howard, B. V., Lee, E. T., Cowan, L. D., Fabsitz, R. R., Howard, W. J., Oopik, A. J., Robbins, D. C., Savage, P. J., Yeh, J. L., & Welty, T. K. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117632 · Cited by 231 · see citing works
Hoy, W. E., Mathews, J. D., McCredie, D. A., Pugsley, D. J., Hayhurst, B. G., Rees, M., Kile, E., Walker, K. A., & Wang, Z. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00099.x · Cited by 219 · see citing works
Rowley, K. G., Daniel, M., Skinner, K., Skinner, M., White, G. A., & O'Dea, K. (2000) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2000.tb00133.x · Cited by 207 · see citing works
U.K. Prospective Diabetes Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.1.87 · Cited by 203 · see citing works
Daniel, M., Green, L. W., Marion, S. A., Gamble, D., Herbert, C. P., Hertzman, C., & Sheps, S. B. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00403-1 · Cited by 130 · see citing works
The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care
Manns, B., Mendelssohn, D. C., & Taub, K. J. (2007) · International Journal of Health Care Finance and Economics · doi:10.1007/s10754-007-9022-y · Cited by 109 · see citing works
Devereux, R. B., Roman, M. J., Paranicas, M., Lee, E. T., Welty, T. K., Fabsitz, R. R., Robbins, D. C., Rhoades, E. R., Rodeheffer, R. J., Cowan, L. D., et al. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113223 · Cited by 109 · see citing works
Pharmacokinetics of Oral Antihyperglycaemic Agents in Patients with Renal Insufficiency
Harrower, A. D. B. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631020-00003 · Cited by 99 · see citing works
Kriska, A. M., Hanley, A. J., Harris, S. B., & Zinman, B. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1787 · Cited by 96 · see citing works
Cardiovascular diseases in a Canadian Arctic population.
Young, T. K., MOFFATT, M. E. K., & O’Neil, J. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.6.881 · Cited by 93 · see citing works
Tobe, S. W. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050030 · Cited by 92 · see citing works
Self-citationWagner, E. H. (2004) · BMJ · doi:10.1136/bmj.328.7433.177 · Cited by 73 · see citing works
Gittelsohn, J., Harris, S. B., Burris, K. L., Kakegamic, L., Landman, L. T., Sharma, A., Wolever, T. M. S., Logan, A. G., Barnie, A., & Zinman, B. (1996) · Health Education Quarterly · doi:10.1177/109019819602300307 · Cited by 69 · see citing works
Dyck, R. F., & Tan, L. (1994) · PubMed · Cited by 66 · see citing works
Menard, J., Payette, H., Baillargeon, J., Maheux, P., Lepage, S., Tessier, D., & Ardilouze, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050054 · Cited by 63 · see citing works
Excessive burden of end-state renal disease among Canadian Indians: a national survey.
Young, T. K., Kaufert, J. M., McKenzie, J. K., Hawkins, A., & O’Neil, J. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.6.756 · Cited by 47 · see citing works
Intensive Diabetes Management: Implications of the DCCT and UKPDS
(2002) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572170202800514 · Cited by 41 · see citing works
Mp, P., Rf, D., & Dc, G. (1997) · PubMed · Cited by 40 · see citing works
Roubideaux, Y. D., MOORE, K. R., Avery, C., Muneta, B., Knight, M., & Buchwald, D. (2000) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572170002600209 · Cited by 38 · see citing works
Gray, R. S., Fabsitz, R. R., Cowan, L. D., Lee, E. T., Tk, W., Jablonski, K., & Howard, B. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801243 · Cited by 36 · see citing works
Improving Diabetes Care in the Primary Health Setting: The Indian Health Service Experience
Gohdes, D., Rith-Najarian, S., Acton, K., & Shields, R. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00013 · Cited by 29 · see citing works
Cardiovascular Disease Risk Factors in Native Americans: A Literature Review
Ellis, J. L., & Campos-Outcalt, D. E. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30582-8 · Cited by 26 · see citing works
Risk factors for cardiovascular disease in individuals with diabetes
Howard, B. V., & Strong Heart Study Investigators (1996) · Acta Diabetologica · doi:10.1007/bf02048540 · Cited by 26 · see citing works
Cardiovascular disease in Navajo Indians with type 2 diabetes.
Hoy, W. E., Light, A., & Megill, D. M. (1995) · PubMed · Cited by 25 · see citing works
Non-diabetic end-stage renal disease among Saskatchewan aboriginal people.
Rf, D., & Tan, L. (1998) · PubMed · Cited by 25 · see citing works
Prevalence of cardiovascular disease risk factors in a southwestern Native American tribe.
Campos-Outcalt, D. E., Ellis, J., Aickin, M. G., Valencia, J., Wunsch, M., & Steele, L. (1995) · PubMed Central · Cited by 22 · see citing works
The Sioux Lookout Diabetes Program: diabetes prevention and management in northwestern Ontario.
Morrison, N., & Dooley, J. (1998) · PubMed · Cited by 19 · see citing works
Diabetic End-Stage Renal Disease Among Native Americans
Muneta, B., Newman, J., Stevenson, J. F., & Eggers, P. W. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.346 · Cited by 18 · see citing works
Aboriginal perspectives of diabetes in a remote community in the Northern Territory
London, J. A., & Guthridge, S. L. (1998) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1998.tb01478.x · Cited by 18 · see citing works
Hoskins, P. L., Alford, J. B., Handelsman, D. J., Yue, D. K., & Turtle, J. R. (1988) · Diabetes Care · doi:10.2337/diacare.11.9.719 · Cited by 18 · see citing works
Effect of Hypertension on Mortality in Pima Indians
Sievers, M. L., Bennett, P. H., Roumain, J., & Nelson, R. G. (1999) · Circulation · doi:10.1161/01.cir.100.1.33 · Cited by 17 · see citing works
Hoy, W. E., Light, A., & Megill, D. M. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.4.321 · Cited by 12 · see citing works
Diabetic nephropathy. Prevention and early referral.
Pylypchuk, G. B., & Beaubien, E. R. (2000) · PubMed · Cited by 10 · see citing works
Self-citationPylypchuk, G. B., & Beaubien, E. R. (2000) · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
1 of the 66 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada Canadian Journal of Diabetes 2003 27 S58 S65 24070926
- 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada Canadian Journal of Diabetes 2008 31 24070961
Cited by
Sorted by citations
Web-Based Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review
Mushcab, H., Kernohan, W. G., Wallace, J., & Martin, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0296 · Cited by 34 · see citing works
- Authors
- Tobe, S. W., Wentworth, J., Ironstand, L., Hartman, S., Hoppe, J., Whiting, J., Kennedy, J., McAllister, C., Kiss, A., Perkins, N., Vincent, L., Pylypchuk, G., & Lewanczuk, R. Z.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- First Nations University of Canada (CA)
- Institute for Clinical Evaluative Sciences (CA)
- St. Paul's Hospital (CA)
- University of Alberta (CA)
- Corresponding author
- Tobe, Sheldon W
- Venue
- BMC Endocrine Disorders
- Published
- 2009-05-09
- Volume
- 9
- Issue
- 1
- Pages
- 13-13
- ISSN
- 1472-6823 (ISSN-L)
- PMC
- PMC2689225
- OpenAlex
- W2044803552
- Cited by
- 2
- References
- 66
- Citations by year
- 2026: 1 · 2015: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Endocrine Disorders (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, remote patient monitoring, home care, diabetes education, rural health care, treatment algorithm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review